Ifp Advisors, Inc Bio Affinity Technologies, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 25,000 shares of BIAF stock, worth $8,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000
Previous 15,000
66.67%
Holding current value
$8,250
Previous $3,000
133.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BIAF
# of Institutions
18Shares Held
522KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA177KShares$58,3760.0% of portfolio
-
Geode Capital Management, LLC Boston, MA119KShares$39,1670.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC53.7KShares$17,7320.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$9,2020.0% of portfolio
-
Warberg Asset Management LLC Winnetka, IL22.5KShares$7,4250.05% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $900K
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...